Pharma drug delivery market worth $1,694.7 billion by 2023
The pharmaceutical drug delivery market could reach $1,694.7 billion by 2023, increasing at a CAGR of 6.4 percent during the period...
List view / Grid view
News
FDA finds another carcinogenic impurity in ARB blood pressure drug
FDA is 'deeply concerned' about a third type of nitrosamine impurity detected in angiotensin II receptor blocker (ARB) medicines...
Six new licensing deals for drug and gene therapy development firm
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector...
Support contracts for environmental monitoring systems
Particle Measuring Systems expands support to ensure monitoring system operations...
Pharma firms accused of illegal agreements over life-saving drug
The CMA provisionally finds Auden Mckenzie and Waymade broke the law by agreeing not to compete for the supply of hydrocortisone tablets to the NHS...
Researchers develop new method for precision drug delivery
Researchers are integrating ultrasound imaging with ultrasound therapy to pave the way for a new kind of drug delivery...
New microscope offers options for drug discovery, safety
Researchers have developed a microscope that may provide insight into how safely and effectively a drug will perform in the body...
Darolutamide NDA to treat non-metastatic castration-resistant prostate cancer
A New Drug Application has been made to the US Food and Drug Administration for the drug darolutamide to treat non-metastatic prostate cancer...
Researchers develop resistance-sensing mechanical injector for therapeutic drug delivery
Researchers have developed a highly sensitive, mechanical needle that targets tissue reliably and precisely for the delivery of therapeutics...
Expansion of the global antibiotics market size
The global antibiotics market is set to increase at a CAGR of 4 percent to $62.06 billion, due to the rising prevalence of infectious diseases...
GORE™ ImproJect™ Plunger for pre-filled syringes at Pharmapack Europe
Gore, a global materials science company, attends Pharmapack Europe to continue their year-long launch of the GORE™ ImproJect™ Plunger for pre-filled syringes...
Brilinta shows promise in phase III clinical trial
Results of a phase III clinical trial suggest that dual antiplatelet therapy may improve outcomes for patients with established coronary artery disease (CAD) and type 2 diabetes....
BPSA releases guide to production of cell and gene therapies
The Bio-Process Systems Alliance, the primary international industry association for single-use bio-processing, is pleased to announce the release of its latest whitepaper...
Danaher acquires GE biopharma for $21.4 billion
General Electric is selling its biopharma business for $21.4 billion, with shares in the company jumping 16 percent upon the news...
European Medicines Agency forced to pay London lease
The European Medicines Agency (EMA) has lost a High Court case, meaning it will have to pay the remaining 20 years left on the lease...
